Micro 3D Printing for Skin Cancer Treatment Device

IMCOMET是一家生物技术初创公司，致力于皮肤癌治疗领域。它的浓度是在肿瘤微环境上。该初创公司正在开创创新的免疫疗法，从而改变了皮肤癌的治疗方式。

Cancer cells fool the immune system by transmitting signals that serve as camouflage. Such signals are molecules, primarily proteins, which tend to produce cancer cells and release them into the fluid around the cells. This fluid is referred to as the microenvironment. The immunotherapy’s goal is to eliminate the camouflage signals, provoke an immune response, and destroy the tumor.

IMCOMET生产了一种基于微针和微流体的技术，可以物理消除肿瘤的微环境及其所有组件，从而用健康的组织代替它们。

M-Duo Technology^®利用彼此靠近并共同发挥作用的小针头。一根针注入载体流体，而另一针将其抽出。

由于流体倾向于在皮肤内的两个针之间传播，因此与细胞液混合并排干该区域的所有信号。这是不断执行的，而无需消除针。

Image Credit: Boston Micro Fabrication

MicroNeedle-Duo（M-DUO）技术使用3D打印的组件，尤其是帽子和盖有针头的盖子。IMCOMET选定的BMF Micro Precision3D printing由于零件的高精度要求而制造此类零件。

该零件由两个100 µm直径的通道组成，并平行于20至40 µm距离。这微观BMF的3D打印机涵盖了纳米3D打印和经典SLA 3D打印之间的技术差距。BMF的3D打印机小型化技术。

Image Credit: Boston Micro Fabrication

This information has been sourced, reviewed and adapted from materials provided by Boston Micro Fabrication (BMF).

有关此消息来源的更多信息，请访问波士顿微型制造（BMF）。